SCHEMBL8312435

SCHEMBL8312435

CC(=O)N1CCN(C(=O)c2ccc(Nc3nccc(-c4ccc(SCCC(C)(C)O)cc4)n3)cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IKBKB O14920 6/20 0.51
▸ CHUK O15111 6/20 0.51
▸ IKBKG Q9Y6K9 5/20 0.51
▸ CDK2 P24941 3/20 0.45
▸ CDK1 P06493 2/20 0.45
▸ JAK2 O60674 8/20 0.44
▸ SYK P43405 2/20 0.44
▸ JAK3 P52333 4/20 0.43
▸ CDK9 P50750 2/20 0.43
▸ AURKA O14965 1/20 0.43
▸ CDK4 P11802 1/20 0.43
▸ CDK7 P50613 1/20 0.43
▸ AURKB Q96GD4 1/20 0.43
▸ PLK4 O00444 1/20 0.43
▸ CCNT1 O60563 1/20 0.43
▸ CCNA2 P20248 1/20 0.43
▸ CCNA1 P78396 1/20 0.43
▸ HDAC3 O15379 1/20 0.43
▸ NCOR1 O75376 1/20 0.43
▸ JAK1 P23458 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8312555 0.92 IKBKB (0.52) IKBKBCHUKIKBKG
SCHEMBL8311749 0.90 IKBKB (0.55) IKBKBCHUKIKBKGCDK2CDK1
SCHEMBL8308936 0.90 CDK2 (0.47) IKBKBCHUKIKBKGCDK2CDK1
SCHEMBL14063857 0.89 IKBKB (0.49) IKBKBCHUKIKBKGCDK2CDK1
SCHEMBL8311902 0.88 IKBKB (0.50) IKBKBCHUKIKBKGCDK2CDK1
SCHEMBL5070979 0.88 IKBKB (0.47) IKBKBCHUKIKBKGCDK2CDK1
SCHEMBL14063867 0.87 JAK2 (0.46) IKBKBCHUKIKBKGCDK2CDK1
SCHEMBL8313335 0.87 IKBKB (0.49) IKBKBCHUKIKBKGCDK2CDK1
SCHEMBL14063861 0.87 IKBKB (0.47) IKBKBCHUKIKBKGCDK2CDK1
SCHEMBL14063864 0.87 IKBKB (0.47) IKBKBCHUKIKBKGCDK2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 — — US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 — — US disclosed
WO-2004084901-A1 METHODS FOR TREATING OR PREVENTING AN INFLAMMATORY OR METABOLIC CONDITION BY INHIBITING JNK SIGNAL PHARMACEUTICALS, LLC (US) 2004-10-07 — — WO disclosed
Send feedback